Secondary outcomes 24–48 hours following surgery
| TAP group (n=59) | Lido group (n=61) | P value | |
| Opioid consumption, IVMEQ | 7.6±3.2 (10) | 6.5±3 (7.5) | 0.5 |
| NRS score at rest | 2.7±2 (2) | 2.8±2 (2) | 0.8 |
| NRS score with activity | 5.3±1.7 (5) | 5.4±1.7 (5) | 0.8 |
| Average NRS score | 3.7±1.9 (3) | 4.3±1.8 (3) | 0.2 |
| Worst NRS score | 6.8±1.5 (6) | 7±1.5 (7) | 0.7 |
| Patient satisfaction, n (%) | 50 (85) | 57 (93) | 0.3 |
| Opioid-related adverse events, n (%) | |||
| Nausea | 8 (14) | 5 (8) | 0.3 |
| Vomiting | 5 (9) | 1 (2) | 0.1 |
| Pruritus | 11 (19) | 12 (20) | 0.9 |
| Creatanine, mg/dL | 5±1.7 (4) | 5.3±1.8 (4) | 0.6 |
Values are shown as geometric mean±SD and (median) or n (%).
IVMEQ, Intravenous Morphine Equivalents; NRS, Numeric Rating Scale; TAP, transversus abdominis plane.